Skip to content

Author

P. Halfmann

We have 3 of 191 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Designing a reoriented H5 hemagglutinin to generate stem-directed, heterosubtypic immunity to influenza A viruses

Human infections with the highly pathogenic avian influenza viruses highlight the risk of novel pandemics, against which seasonal vaccines provide limited cross-protection. Whereas antibody responses to current vaccine candidates are typically biased toward the immunodominant and variable head region of hemagglutinin (...

Nicholas A. Miller, Tong Wang, Jung-Ho Choi et al. · 0 citations
Open access Aug 2026

Discovery of a 4′‐Azido Fleximer Nucleoside Analog With Broad‐Spectrum Antiviral Activity Against DENV, EBOV, and Other RNA Viruses

The ongoing emergence and reemergence of RNA viruses from multiple viral families highlights the urgent need for broad‐spectrum antiviral therapeutics. To address this issue, a series of 4′‐azido fleximer nucleoside analogs were synthesized and evaluated for broad‐spectrum antiviral activity against pathogens of epidem...

Kyle A. Davis, Ryan L. Slack, Thomas R. Foulkes et al. · 0 citations
Open access Aug 2026

A rapidly deployable CRISPR–Cas3 diagnostic platform for emerging RNA viruses

The analytical feasibility of a rapidly adaptable CRISPR–Cas3 engineering framework for decentralized detection of emerging RNA viruses is established, establishing the analytical feasibility of a rapidly adaptable CRISPR–Cas3 engineering framework for decentralized detection of emerging RNA viruses.

Jun Nakamura, Kaya Miyazaki-Iida, Shotaro Torii et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.